Peptide record

TPDB55165

Peptide YY (3-36) Blood-Brain Barrier Neuropeptide standard
34 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB55165
Peptide YY (3-36)
Blood-Brain Barrier Neuropeptide
Delivery and barrier-penetrating peptides Neuroactive peptides
BBPpredict Peptipedia
standard
No
A 34-aa standard-residue multi-activity (Blood-Brain Barrier and Neuropeptide) peptide sequence curated from BBPpredict and Peptipedia, with an available 3D structural model.
Sequence
IKPEAPGEDASPEELNRYYASLRHYLNLVTRQRY
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C180H278N52O55
CMFW
RELY
4050.50
7.63
6
5
13
+0
2.93
-1.074
74.71
Mammalian: 20 hour Yeast: 30 min E.coli: >10 hour
5960
1.47
10
Residue Composition
number
3
A
4
R
2
N
1
D
0
C
4
E
1
Q
1
G
1
H
1
I
4
L
1
K
0
M
0
F
3
P
2
S
1
T
0
W
4
Y
1
V
Amino Acid Distribution
A: 3 R: 4 N: 2 D: 1 C: 0 E: 4 Q: 1 G: 1 H: 1 I: 1 L: 4 K: 1 M: 0 F: 0 P: 3 S: 2 T: 1 W: 0 Y: 4 V: 1
Chemical Descriptors
34 reviewed residue count
C180H278N52O55 sequence-only estimate (linear, free termini)
4050.50 sequence-only estimate (linear, free termini)
7.63 sequence-only estimate (linear, free termini)
+0 sequence-only estimate (linear, free termini)
2.93 sequence-only estimate (linear, free termini)
-1.074 sequence-only estimate (linear, free termini)
Linear Activity
Ile-Lys-Pro-Glu-Ala-Pro-Gly-Glu-Asp-Ala-Ser-Pro-Glu-Glu-Leu-Asn-Arg-Tyr-Tyr-Ala-Ser-Leu-Arg-His-Tyr-Leu-Asn-Leu-Val-Thr-Arg-Gln-Arg-Tyr Activity
Evidence Records 11 records
Evidence 1 Activity

Activity

Blood-Brain Barrier
0.0183 min-1

Assay & Model

Efflux study ICU
Brain elemination rate constant

Source & Reference

NA
B3Pdb

Other

Chemically synthesized
Permeability
Direct iodination
Evidence 2 Activity

Activity

Blood-Brain Barrier
37.8 min

Assay & Model

Efflux study ICU
half life, brain

Source & Reference

NA
B3Pdb

Other

Chemically synthesized
Permeability
Direct iodination
Evidence 3 Activity

Activity

Blood-Brain Barrier
26.56 %/g

Assay & Model

Efflux study ICU
% injected dose

Source & Reference

NA
B3Pdb

Other

Chemically synthesized
Permeability
Direct iodination
Evidence 4 Activity

Activity

Blood-Brain Barrier
0.00234 mL/(g x min)

Assay & Model

Unidirectional flux rate constant

Source & Reference

NA
B3Pdb

Other

Chemically synthesized
in situ brain perfusion
non saturable
Direct iodination
Evidence 5 Activity

Activity

Blood-Brain Barrier
69%

Assay & Model

Capillary depletion
% parenchyma

Source & Reference

NA
B3Pdb

Other

Chemically synthesized
non saturable
Direct iodination
Evidence 6 Activity

Activity

Blood-Brain Barrier
0.0011 ml/g

Assay & Model

Capillary depletion
Capillary depletion (capillary/serum)

Source & Reference

NA
B3Pdb

Other

Chemically synthesized
non saturable
Direct iodination
Evidence 7 Activity

Activity

Blood-Brain Barrier
0.00247 ml/g

Assay & Model

Capillary depletion
Capillary depletion (parenchyma/serum)

Source & Reference

NA
B3Pdb

Other

Chemically synthesized
non saturable
Direct iodination
Evidence 8 Activity

Activity

Blood-Brain Barrier
31%

Assay & Model

Capillary depletion
% capillary

Source & Reference

NA
B3Pdb

Other

Chemically synthesized
non saturable
Direct iodination
Evidence 9 Activity

Activity

Blood-Brain Barrier
0.00049 mL/(g x min)

Assay & Model

Unidirectional influx rate constant

Source & Reference

NA
B3Pdb

Other

Chemically synthesized
Intravenous
non saturable
Direct iodination
Evidence 10 Activity

Activity

Blood-Brain Barrier
0.012 ml/g

Assay & Model

Initial disrobution volume

Source & Reference

NA
B3Pdb

Other

Chemically synthesized
Intravenous
non saturable
Direct iodination
Evidence 11 Activity

Activity

Blood-Brain Barrier
0.176 %/g

Assay & Model

% injected dose

Source & Reference

NA
B3Pdb

Other

Chemically synthesized
Intravenous
non saturable
Direct iodination
Additional Detail Fields 1 fields
in situ brain perfusion Intravenous